PortfoliosLab logoPortfoliosLab logo
SURI vs. XPH
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

SURI vs. XPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Simplify Propel Opportunities ETF (SURI) and SPDR S&P Pharmaceuticals ETF (XPH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SURI vs. XPH - Yearly Performance Comparison


2026 (YTD)202520242023
SURI
Simplify Propel Opportunities ETF
-2.66%28.32%-13.34%-2.87%
XPH
SPDR S&P Pharmaceuticals ETF
-3.32%31.60%4.94%-2.89%

Returns By Period

In the year-to-date period, SURI achieves a -2.66% return, which is significantly higher than XPH's -3.32% return.


SURI

1D
2.27%
1M
-6.14%
YTD
-2.66%
6M
8.30%
1Y
19.80%
3Y*
7.84%
5Y*
10Y*

XPH

1D
5.32%
1M
-5.56%
YTD
-3.32%
6M
13.19%
1Y
24.45%
3Y*
11.04%
5Y*
2.79%
10Y*
3.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SURI vs. XPH - Expense Ratio Comparison

SURI has a 2.51% expense ratio, which is higher than XPH's 0.35% expense ratio.


Return for Risk

SURI vs. XPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SURI
SURI Risk / Return Rank: 4040
Overall Rank
SURI Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
SURI Sortino Ratio Rank: 4343
Sortino Ratio Rank
SURI Omega Ratio Rank: 3838
Omega Ratio Rank
SURI Calmar Ratio Rank: 3939
Calmar Ratio Rank
SURI Martin Ratio Rank: 3636
Martin Ratio Rank

XPH
XPH Risk / Return Rank: 5959
Overall Rank
XPH Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
XPH Sortino Ratio Rank: 5959
Sortino Ratio Rank
XPH Omega Ratio Rank: 5050
Omega Ratio Rank
XPH Calmar Ratio Rank: 7171
Calmar Ratio Rank
XPH Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SURI vs. XPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Simplify Propel Opportunities ETF (SURI) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SURIXPHDifference

Sharpe ratio

Return per unit of total volatility

0.76

1.00

-0.25

Sortino ratio

Return per unit of downside risk

1.19

1.47

-0.28

Omega ratio

Gain probability vs. loss probability

1.15

1.19

-0.04

Calmar ratio

Return relative to maximum drawdown

0.99

1.77

-0.77

Martin ratio

Return relative to average drawdown

3.33

5.52

-2.19

SURI vs. XPH - Sharpe Ratio Comparison

The current SURI Sharpe Ratio is 0.76, which is comparable to the XPH Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of SURI and XPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


SURIXPHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.76

1.00

-0.25

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.17

Sharpe Ratio (All Time)

Calculated using the full available price history

0.06

0.38

-0.32

Correlation

The correlation between SURI and XPH is 0.59, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

SURI vs. XPH - Dividend Comparison

SURI's dividend yield for the trailing twelve months is around 17.49%, more than XPH's 0.69% yield.


TTM20252024202320222021202020192018201720162015
SURI
Simplify Propel Opportunities ETF
17.49%16.31%21.41%14.71%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XPH
SPDR S&P Pharmaceuticals ETF
0.69%0.83%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%

Drawdowns

SURI vs. XPH - Drawdown Comparison

The maximum SURI drawdown since its inception was -47.76%, roughly equal to the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for SURI and XPH.


Loading graphics...

Drawdown Indicators


SURIXPHDifference

Max Drawdown

Largest peak-to-trough decline

-47.76%

-48.03%

+0.27%

Max Drawdown (1Y)

Largest decline over 1 year

-16.94%

-13.15%

-3.79%

Max Drawdown (5Y)

Largest decline over 5 years

-31.63%

Max Drawdown (10Y)

Largest decline over 10 years

-35.97%

Current Drawdown

Current decline from peak

-24.28%

-7.29%

-16.99%

Average Drawdown

Average peak-to-trough decline

-17.42%

-17.37%

-0.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.18%

5.23%

-0.05%

Volatility

SURI vs. XPH - Volatility Comparison

The current volatility for Simplify Propel Opportunities ETF (SURI) is 7.04%, while SPDR S&P Pharmaceuticals ETF (XPH) has a volatility of 9.49%. This indicates that SURI experiences smaller price fluctuations and is considered to be less risky than XPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


SURIXPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.04%

9.49%

-2.45%

Volatility (6M)

Calculated over the trailing 6-month period

16.73%

16.38%

+0.35%

Volatility (1Y)

Calculated over the trailing 1-year period

26.36%

24.72%

+1.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.62%

20.56%

+8.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

28.62%

22.22%

+6.40%